(RTTNews) - Repligen Corp. (RGEN), a bioprocessing company, on Friday announced agreements to issue $1 billion in 0.25% convertible senior notes due 2031.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。
Veytics Intelligence
Repligen Announces $1 Bln Convertible Notes Offering To Extend Debt Maturity
